Get the Stockscreener App
2.65
2.57%
-0.07
Immix Biopharma Inc stock is traded at $2.65, with a volume of 181.09K.
It is down -2.57% in the last 24 hours and up +21.00% over the past month.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
See More
Previous Close:
$2.72
Open:
$2.72
24h Volume:
181.09K
Relative Volume:
0.71
Market Cap:
$73.87M
Revenue:
-
Net Income/Loss:
$-14.14M
P/E Ratio:
-2.8804
EPS:
-0.92
Net Cash Flow:
$-12.64M
1W Performance:
-2.21%
1M Performance:
+21.00%
6M Performance:
+36.60%
1Y Performance:
+27.40%
1-Day Range:
$2.63
$2.79
1-Week Range:
$2.63
$2.89
52-Week Range:
$1.26
$3.12
Immix Biopharma Inc Stock (IMMX) Company Profile
Name
Immix Biopharma Inc
Sector
Industry
Phone
(888) 958-1084
Address
11400 WEST OLYMPIC BLVD., LOS ANGELES
Compare IMMX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
2.65 | 75.83M | 0 | -14.14M | -12.64M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Immix Biopharma Inc Stock (IMMX) Latest News
How strong is Immix Biopharma Inc. company’s balance sheetExpert Picks Entry Points For 2025 - jammulinksnews.com
Real time alert setup for Immix Biopharma Inc. performanceFree Low Risk High Return Opportunities - Newser
Is Immix Biopharma Inc. a growth stock or a value stockSwing Trade Forecasts For Smart Trading - jammulinksnews.com
What are Immix Biopharma Inc. company’s key revenue driversPost Market Recommendation With High Returns - jammulinksnews.com
Is Immix Biopharma Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Triple Digit Growth Focused Trade Plan - Newser
Live market analysis of Immix Biopharma Inc.Pattern Breakout Prediction for Short Term - Newser
Using Ichimoku Cloud for Immix Biopharma Inc. technicalsFree High Yield Stock Screening Results - Newser
Real time social sentiment graph for Immix Biopharma Inc.Free Pattern Breakout Entry Stock Forecast - Newser
Why Immix Biopharma Inc. stock attracts strong analyst attentionAsset Safety Selection Using Quantitative Analysis - Newser
Volume Profile Shows Strong Base for Immix Biopharma Inc.Stock Market Entry Timing Signals Revealed - metal.it
When is Immix Biopharma Inc. stock expected to show significant growthLow Risk Watchlist That Work - jammulinksnews.com
How does Immix Biopharma Inc. compare to its industry peersGet real-time alerts on high-potential stocks - jammulinksnews.com
What institutional investors are buying Immix Biopharma Inc. stockUnlock powerful stock screening tools - jammulinksnews.com
How volatile is Immix Biopharma Inc. stock compared to the marketCapitalize on high-yield stocks early - jammulinksnews.com
Should I hold or sell Immix Biopharma Inc. stock in 2025Get daily updates on the hottest stocks - jammulinksnews.com
Is it the right time to buy Immix Biopharma Inc. stockUnstoppable trading performance - jammulinksnews.com
Why is Immix Biopharma Inc. stock attracting strong analyst attentionUnlock daily trading alerts for profits - jammulinksnews.com
Published on: 2025-07-28 00:33:58 - jammulinksnews.com
What are the technical indicators suggesting about Immix Biopharma Inc.Explosive capital gains - jammulinksnews.com
Will Immix Biopharma Inc. Stock Benefit from AI and Green Energy TrendsFree Access to Community with 300% Return - Newser
Is Immix Biopharma Inc. stock a growth or value playFree Predictions - jammulinksnews.com
What drives Immix Biopharma Inc. stock priceUnstoppable investment returns - PrintWeekIndia
Is Immix Biopharma Inc. a good long term investmentFree Stock Market Mentorship - Autocar Professional
What analysts say about Immix Biopharma Inc. stockFree Stock Market Knowledge Sharing - Autocar Professional
Immix Biopharma Inc. Stock Analysis and ForecastUnrivaled growth potential - jammulinksnews.com
Immix Biopharma Inc Stock (IMMX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Immix Biopharma Inc Stock (IMMX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Morris Gabriel S | CFO |
Jun 18 '25 |
Buy |
2.28 |
2,225 |
5,071 |
288,059 |
| Hsu Jason | Director |
Dec 23 '24 |
Buy |
2.19 |
40,000 |
87,680 |
893,000 |
| Hsu Jason | Director |
Dec 20 '24 |
Buy |
2.17 |
7,700 |
16,678 |
853,000 |
| Hsu Jason | Director |
Aug 21 '24 |
Buy |
2.23 |
15,000 |
33,390 |
837,200 |
| Hsu Jason | Director |
Aug 22 '24 |
Buy |
2.25 |
8,100 |
18,233 |
845,300 |
| Ng Carey | Director |
Aug 16 '24 |
Buy |
1.86 |
10,000 |
18,600 |
20,000 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):